カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

世界の感染監視ソリューション市場（～2027）：ソフトウェア別、サービス別、エンドユーザー別、地域別

■ 英語タイトル：Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities), and Region- Global Forecast to 2027

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：HIT4380-23）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：HIT4380-23
■ 発行日：2023年2月15日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：258
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の感染監視ソリューション市場（～2027）：ソフトウェア別、サービス別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

MarketsandMarkets社の本市場調査レポートでは、世界の感染監視ソリューション市場規模が2022年に577百万ドルに達し、2027年には1,100百万ドルに成長すると推測しています。また、予測期間中CAGR13.8%で拡大すると予想しています。本書は、感染監視ソリューションの世界市場について総合的に分析・調査を行い、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業動向、製品・サービス別（ソフトウェア、サービス）分析、エンドユーザー別（病院、長期介護施設、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報など、以下の構成で整理しています。主要企業情報として、Dickinson and Company (US)、Premier、Inc. (US)、Wolters Kluwer N.V. (Netherlands)、Cerner Corporation (US)、Baxter International Inc. (US)などの情報が含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業動向
・世界の感染監視ソリューション市場規模：製品・サービス別
- ソフトウェアの市場規模
- サービスの市場規模
・世界の感染監視ソリューション市場規模：エンドユーザー別
- 病院における市場規模
- 長期介護施設における市場規模
- その他における市場規模
・世界の感染監視ソリューション市場規模：地域別
- 北米の感染監視ソリューション市場規模
- ヨーロッパの感染監視ソリューション市場規模
- アジア太平洋の感染監視ソリューション市場規模
- 中南米の感染監視ソリューション市場規模
- 中東・アフリカの感染監視ソリューション市場規模
・競争状況
・企業情報

“感染監視ソリューション市場は、2022年の推定5億7700万米ドルから2027年には11億米ドルに成長し、予測期間中の年平均成長率は13.8%と予測”
同市場は、需要の増加、院内感染の流行、外科手術の増加、医療費の増加などの要因から、有望な成長ポテンシャルを秘めています。しかし、熟練した医療IT専門家の不足とデータセキュリティの懸念が、この市場の成長をある程度制限すると予想されます。

“トレーニング＆コンサルティングサービス感染監視サービス市場のタイプ別急成長セグメント”
トレーニング＆コンサルティングサービスは、予測期間中、感染監視サービス市場で最も急成長が見込まれます。トレーニングおよびコンサルティングサービスは、市場で入手可能な最新の感染監視ソリューションに対する医療従事者の認識を高めます。大手・中堅企業の多くは、感染サーベイランスソフトウェアを使用する病院、独立系検査室、医院検査室に積極的に技術支援を行っています。価値観に基づく医療の重要性の高まり、技術の進歩、医療における統合の進展といった要因が、コンサルティングサービス市場を牽引しています。

“予測期間中、大規模病院がタイプ別で最大の病院向け感染監視ソリューション市場になると予測”
タイプ（病床数）に基づき、病院は大規模病院（450床超）、中規模病院（250〜449床）、小規模病院（249床未満）に区分されます。病院向け感染監視ソリューション市場では、大規模病院セグメントが最大のシェアを占めています。中国やその他の発展途上国では私立病院の数が増加しており、ICUや病院のその他の部門に導入される技術的に高度なHCITソリューションの需要が高まると予想されます。さらに、病院の規模が大きくなるにつれて、より多くの患者を継続的に監視する必要があるため、HAI管理の複雑さが増しています。

“予測期間中、感染監視ソリューション市場で欧州が第2位のシェアを占める”
予測期間中、欧州は感染監視ソリューション市場で第2位のシェアを占めました。欧州市場の成長の背景には、HCITソリューションの採用増加、HAIの発生率の増加、手術件数の増加、高齢者人口の増加があります。患者の転帰を改善する必要性の高まりが、この地域全体で感染監視ソリューションの採用に寄与しています。欧州では、病院や長期介護施設の感染予防戦略として、いくつかの政策やガイドラインが実施されており、これが同地域における感染監視ソリューションの需要を促進しています。

主な参加企業の内訳は以下の通りです：
– 企業タイプ別 – Tier 1-40%, Tier 2-35%, Tier 3-25％
– 役職別 – Cレベル-35%、ディレクターレベル-25%、その他-40％
– 地域別 – 北米-45%、欧州-30%、アジア太平洋地域-20%、中南米-3%、中東・アフリカ-2％

感染監視ソリューション市場の主要企業：
感染監視ソリューション市場で事業を展開する主要企業には、Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US)などが含まれます。

調査範囲
当レポートでは、感染監視ソリューション市場を分析し、製品・サービス、エンドユーザー、地域などの様々なセグメントに基づいて、市場規模や今後の成長可能性を推計することを目的としています。また、市場で入手可能な様々な感染監視ソリューション製品＆サービスの製品ポートフォリオマトリックスも掲載しています。また、同市場における主要企業の競合分析、企業プロフィール、製品提供、主要市場戦略も掲載しています。

レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業も市場の動向を把握するのに役立ちます。本レポートを購入された企業は、以下の戦略のいずれか、または任意の組み合わせを使用して、市場での地位を強化することができます。

本レポートは、以下のポイントに関する洞察を提供します：
– 市場参入： 世界の感染監視ソリューション市場のトップ企業が提供する製品ポートフォリオに関する包括的な情報。製品・サービス別、エンドユーザー別に市場を分析
– 製品の強化/革新： 感染監視ソリューションの世界市場における今後の動向と製品発売に関する詳細な洞察
– 市場開発： 製品・サービス別、エンドユーザー別の有利な新興市場に関する包括的情報
– 市場の多様化： 世界の感染監視ソリューション市場における新製品や製品強化、成長地域、最近の開発、投資に関する詳細情報
– 競合評価： 感染監視ソリューションの世界市場における主要企業の市場シェア、成長戦略、製品提供、競合のリーダーシップマッピング、能力に関する詳細な評価

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS AND EXCLUSIONS 35
1.3 MARKET SEGMENTATION 35
FIGURE 1 INFECTION SURVEILLANCE SOLUTIONS MARKET SEGMENTATION 35
1.4 YEARS CONSIDERED 36
1.5 CURRENCY CONSIDERED 36
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 36
1.6 STAKEHOLDERS 37
1.7 SUMMARY OF CHANGES 37
1.8 RECESSION IMPACT 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH APPROACH 39
FIGURE 2 INFECTION SURVEILLANCE SOLUTIONS MARKET: RESEARCH DESIGN 40
2.2 RESEARCH METHODOLOGY DESIGN 41
2.2.1 SECONDARY RESEARCH 42
2.2.1.1 Key data from secondary sources 43
2.2.2 PRIMARY DATA 43
FIGURE 3 PRIMARY SOURCES 44
2.2.2.1 Key data from primary sources 45
2.2.2.2 Key insights from primary experts 46
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 46
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 47
2.3 MARKET SIZE ESTIMATION: INFECTION SURVEILLANCE SOLUTIONS MARKET 47
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 48
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION 49
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
FIGURE 9 CAGR PROJECTIONS 52
FIGURE 10 TOP-DOWN APPROACH 52
2.4 DATA TRIANGULATION APPROACH 54
FIGURE 11 DATA TRIANGULATION METHODOLOGY 54
2.5 MARKET SHARE ESTIMATION 55
2.6 ASSUMPTIONS FOR THE STUDY 55

2.7 LIMITATIONS 56
2.7.1 METHODOLOGY-RELATED LIMITATIONS 56
2.7.2 SCOPE-RELATED LIMITATIONS 56
2.8 RISK ASSESSMENT 56
TABLE 2 RISK ASSESSMENT: INFECTION SURVEILLANCE SOLUTIONS MARKET 56
3 EXECUTIVE SUMMARY 57
FIGURE 12 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 57
FIGURE 13 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 58
FIGURE 14 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 58
FIGURE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 59
FIGURE 16 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT, 2021 60
4 PREMIUM INSIGHTS 61
4.1 INFECTION SURVEILLANCE SOLUTIONS MARKET OVERVIEW 61
FIGURE 17 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET GROWTH 61
4.2 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY END USER AND COUNTRY 62
FIGURE 18 HOSPITALS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2021 62
4.3 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 63
FIGURE 19 CHINA TO REGISTER HIGHEST REVENUE GROWTH FROM 2022 TO 2027 63
4.4 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION (2020–2027) 64
FIGURE 20 NORTH AMERICA TO DOMINATE INFECTION SURVEILLANCE SOLUTIONS MARKET DURING FORECAST PERIOD 64
4.5 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS 64
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MARKET DYNAMICS 65
TABLE 3 MARKET DYNAMICS: INFECTION SURVEILLANCE SOLUTIONS MARKET 65
5.2.1 MARKET DRIVERS 66
5.2.1.1 Increasing prevalence of hospital-acquired infections 66
5.2.1.2 Increasing adoption of antimicrobial stewardship programs 67
5.2.1.3 Increasing number of surgeries 67
TABLE 4 US: PERCENTAGE INCREASE IN SURGICAL VOLUMES 67
5.2.1.4 Growing geriatric population and increasing incidence of chronic diseases 68
5.2.1.5 Growing investments to improve healthcare systems 69
5.2.2 MARKET RESTRAINTS 69
5.2.2.1 High cost of deployment for small healthcare organizations 69
TABLE 5 AVERAGE SELLING PRICE OF HEALTHCARE IT SOLUTIONS, BY PRODUCT, 2021 70
5.2.2.2 Reluctance among medical professionals to adopt advanced healthcare IT solutions 70
5.2.3 MARKET OPPORTUNITIES 71
5.2.3.1 Increasing consolidation in healthcare industry 71
5.2.3.2 Cloud-based software solutions 71
5.2.3.3 Emerging markets 71
5.2.4 MARKET CHALLENGES 72
5.2.4.1 Shortage of skilled healthcare IT professionals 72
5.2.4.2 Data security concerns 72
6 INDUSTRY TRENDS 73
6.1 INTRODUCTION 73
6.2 INDUSTRY TRENDS 73
6.2.1 SHIFT TOWARD WEB-BASED SOLUTIONS 73
6.2.2 AI-POWERED SURVEILLANCE SOFTWARE 73
6.2.3 SHIFT TOWARD AUTOMATION IN HEALTHCARE FACILITIES 74
6.2.4 INFECTION SURVEILLANCE USING MOBILE APPLICATION TOOLS 74
6.3 REGULATORY ANALYSIS 74
6.3.1 NORTH AMERICA 74
TABLE 6 NORTH AMERICA: REGULATIONS AND LAWS 75
6.3.2 EUROPE 76
TABLE 7 EUROPE: REGULATIONS AND LAWS 76
6.3.3 ASIA 77
TABLE 8 ASIA: REGULATIONS AND LAWS 77
6.3.4 MIDDLE EAST & AFRICA 78
TABLE 9 MIDDLE EAST & AFRICA: REGULATIONS AND LAWS 78
6.3.5 LATIN AMERICA 78
TABLE 10 LATIN AMERICA: REGULATIONS AND LAWS 78
TABLE 11 KEY GLOBAL REGULATIONS & STANDARDS GOVERNING INFECTION SURVEILLANCE SOLUTIONS 79
6.4 TECHNOLOGY ANALYSIS 80
6.4.1 CLOUD COMPUTING TECHNOLOGY 80
6.4.2 ARTIFICIAL INTELLIGENCE 80
TABLE 12 AI IN HEALTHCARE MARKET, BY REGION, 2017–2020 (USD MILLION) 80
TABLE 13 AI IN HEALTHCARE MARKET, BY REGION, 2021–2027 (USD MILLION) 81
6.4.3 BLUETOOTH LOW-ENERGY SENSORS 81
6.5 ECOSYSTEM ANALYSIS 81
FIGURE 22 HEALTHCARE IT MARKET: ECOSYSTEM ANALYSIS 81
FIGURE 23 INFECTION SURVEILLANCE SOLUTIONS MARKET: ECOSYSTEM ANALYSIS 82
6.6 PATENT ANALYSIS 82
6.6.1 PATENT PUBLICATION TRENDS FOR INFECTION SURVEILLANCE SOLUTIONS 82
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2012–JANUARY 2023) 83
6.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS 83
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012– JANUARY 2023) 84
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012–JANUARY 2023) 85
TABLE 14 INFECTION SURVEILLANCE SOLUTIONS: LIST OF PATENTS/PATENT APPLICATIONS, 2020–2022 85
6.7 IMPACT OF RECESSION 88
7 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE 89
7.1 INTRODUCTION 90
TABLE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 90
7.2 SOFTWARE 90
TABLE 16 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 17 INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.1 ON-PREMISE SOFTWARE 93
7.2.1.1 Data protection and in-house access to HCIT solutions to drive market 93
TABLE 18 ON-PREMISE SOFTWARE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 93
TABLE 19 ON-PREMISE SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.2 WEB-BASED SOFTWARE 95
7.2.2.1 Increasing demand for data centralization and cost-benefits of solutions to drive adoption 95
TABLE 20 WEB-BASED SOFTWARE OFFERED BY KEY MARKET PLAYERS 95
TABLE 21 WEB-BASED SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.3 SERVICES 97
TABLE 22 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 23 INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
7.3.1 PRODUCT SUPPORT & MAINTENANCE SERVICES 98
7.3.1.1 Rising reliance on outsourcing HCIT support to boost demand 98
TABLE 24 PRODUCT SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
7.3.2 TRAINING & CONSULTING SERVICES 100
7.3.2.1 Need to develop IT infrastructure and demand for expert assistance to offer growth opportunities 100
TABLE 25 TRAINING & CONSULTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
7.3.3 IMPLEMENTATION SERVICES 101
7.3.3.1 Focus on ensuring regulatory compliance among end users to boost service sector growth 101
TABLE 26 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
8 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER 102
8.1 INTRODUCTION 103
TABLE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 103
8.2 HOSPITALS 103
TABLE 28 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 29 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 104
8.2.1 LARGE HOSPITALS 105
8.2.1.1 Growing need to deploy cloud-based solutions to drive growth 105
TABLE 30 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LARGE HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 105
8.2.2 MEDIUM-SIZED HOSPITALS 106
8.2.2.1 Increasing demand for more specialized and advanced care to boost market 106
TABLE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR MEDIUM-SIZED HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 106
8.2.3 SMALL HOSPITALS 107
8.2.3.1 Need to decrease operational costs and growing competition to support adoption 107
TABLE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SMALL HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 107
8.3 LONG-TERM CARE FACILITIES 108
TABLE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 34 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION) 109
8.3.1 NURSING HOMES 109
8.3.1.1 Growing geriatric population to favor end-user growth 109
TABLE 35 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR NURSING HOMES, BY COUNTRY, 2020–2027 (USD MILLION) 110
8.3.2 SKILLED NURSING FACILITIES 110
8.3.2.1 Advancements in HCIT solutions to favor adoption in SNFs 110
TABLE 36 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SKILLED NURSING FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION) 111
8.3.3 ASSISTED LIVING FACILITIES 111
8.3.3.1 ALFs to show significant growth alongside rising geriatric population 111
TABLE 37 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION) 112
8.4 OTHER END USERS 112
TABLE 38 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 113
9 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION 114
9.1 INTRODUCTION 115
FIGURE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT (2020–2027) 115
TABLE 39 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 116
9.2 NORTH AMERICA 116
9.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION 117
FIGURE 28 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT 117
TABLE 40 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 41 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 118
TABLE 42 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 43 NORTH AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 44 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 119
TABLE 45 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 46 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 120
9.2.2 US 120
9.2.2.1 Advanced medical infrastructure and increasing healthcare expenditure to drive market growth 120
TABLE 47 US: KEY MACROINDICATORS 121
TABLE 48 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 121
TABLE 49 US: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 50 US: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 51 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
TABLE 52 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 53 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 123
9.2.3 CANADA 123
9.2.3.1 Rising adoption of advanced HCIT solutions to propel market growth 123
TABLE 54 CANADA: KEY MACROINDICATORS 124
TABLE 55 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 125
TABLE 56 CANADA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 57 CANADA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 58 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
TABLE 59 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 60 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 126
9.3 EUROPE 127
9.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION 127
TABLE 61 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 62 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 128
TABLE 63 EUROPE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 64 EUROPE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 65 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
TABLE 66 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 67 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 130
9.3.2 GERMANY 130
9.3.2.1 Germany to hold largest share of European market 130
TABLE 68 GERMANY: KEY MACROINDICATORS 131
TABLE 69 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 131
TABLE 70 GERMANY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 71 GERMANY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 72 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 132
TABLE 73 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 74 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 133
9.3.3 FRANCE 133
9.3.3.1 High healthcare spending and favorable government initiatives to drive market growth in France 133
TABLE 75 FRANCE: KEY MACROINDICATORS 134
TABLE 76 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134
TABLE 77 FRANCE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 78 FRANCE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 79 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 135
TABLE 80 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 81 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 136
9.3.4 UK 136
9.3.4.1 Rising number of surgeries and implementation of favorable government initiatives to drive market growth in the UK 136
TABLE 82 UK: KEY MACROINDICATORS 137
TABLE 83 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 137
TABLE 84 UK: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 85 UK: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 86 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 138
TABLE 87 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 88 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 139
9.3.5 ITALY 139
9.3.5.1 Increasing adoption of eHealth technologies to propel market growth in Italy 139
TABLE 89 ITALY: KEY MACROINDICATORS 140
TABLE 90 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 140
TABLE 91 ITALY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 92 ITALY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 93 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 141
TABLE 94 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 95 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 142
9.3.6 SPAIN 142
9.3.6.1 Emphasis on infrastructural improvement and rising disease prevalence to contribute to growth 142
TABLE 96 SPAIN: KEY MACROINDICATORS 143
TABLE 97 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 143
TABLE 98 SPAIN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 99 SPAIN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 100 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 144
TABLE 101 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 102 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 145
9.3.7 SWITZERLAND 145
9.3.7.1 Increasing demand for healthcare services and growing healthcare awareness to augment market 145
TABLE 103 SWITZERLAND: KEY MACROINDICATORS 146
TABLE 104 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 146
TABLE 105 SWITZERLAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 106 SWITZERLAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 107 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 147
TABLE 108 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 109 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 148
9.3.8 NETHERLANDS 148
9.3.8.1 Increasing healthcare initiatives to favor demand growth 148
TABLE 110 NETHERLANDS: KEY MACROINDICATORS 149
TABLE 111 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 149
TABLE 112 NETHERLANDS: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 113 NETHERLANDS: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 114 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 150
TABLE 115 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 116 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 151
9.3.9 REST OF EUROPE 151
TABLE 117 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 152
TABLE 118 ROE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 119 ROE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 120 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 153
TABLE 121 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 122 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 153
9.4 ASIA PACIFIC 154
9.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION 154
FIGURE 29 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT 155
TABLE 123 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 156
TABLE 124 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 156
TABLE 125 ASIA PACIFIC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 126 ASIA PACIFIC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 127 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 157
TABLE 128 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 129 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 158
9.4.2 JAPAN 158
9.4.2.1 Japan to dominate APAC market over forecast period 158
TABLE 130 JAPAN: KEY MACROINDICATORS 159
TABLE 131 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 159
TABLE 132 JAPAN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 133 JAPAN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 134 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 160
TABLE 135 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 136 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 161
9.4.3 CHINA 161
9.4.3.1 Healthcare infrastructure improvements in China to contribute to market growth 161
TABLE 137 CHINA: KEY MACROINDICATORS 162
TABLE 138 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 162
TABLE 139 CHINA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 140 CHINA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 141 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 163
TABLE 142 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 143 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 164
9.4.4 INDIA 164
9.4.4.1 Increasing demand for HCIT solutions to support market growth 164
TABLE 144 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 165
TABLE 145 INDIA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 146 INDIA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 147 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 166
TABLE 148 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 149 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 167
9.4.5 AUSTRALIA AND NEW ZEALAND 167
9.4.5.1 Increasing number of hospitalizations and government initiatives for infection prevention to drive market growth in ANZ 167
TABLE 150 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 168
TABLE 151 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 152 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 153 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 169
TABLE 154 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 155 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 170
9.4.6 SOUTH KOREA 170
9.4.6.1 Increasing medical tourism to boost market 170
TABLE 156 SOUTH KOREA: KEY MACROINDICATORS 171
TABLE 157 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 171
TABLE 158 SOUTH KOREA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 159 SOUTH KOREA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 160 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 172
TABLE 161 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 162 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 173
9.4.7 REST OF ASIA PACIFIC 173
TABLE 163 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 174
TABLE 164 ROAPAC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 165 ROAPAC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 166 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 175
TABLE 167 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 168 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 175
9.5 LATIN AMERICA 176
9.5.1 FAVORABLE HCIT INITIATIVES TO DRIVE MARKET GROWTH 176
9.5.2 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION 177
TABLE 169 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 177
TABLE 170 LATIN AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 171 LATIN AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 172 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 178
TABLE 173 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 174 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 179
9.6 MIDDLE EAST & AFRICA 179
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH 179
9.6.2 MIDDLE EAST AND AFRICA: IMPACT OF ECONOMIC RECESSION 180
TABLE 175 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 180
TABLE 176 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 177 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 178 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 181
TABLE 179 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 180 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020–2027 (USD MILLION) 182
10 COMPETITIVE LANDSCAPE 183
10.1 OVERVIEW 183
10.2 KEY PLAYER STRATEGIES 183
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS 184
10.3 ADOPTION TRENDS FOR INNOVATIVE SOLUTIONS 186
10.4 REVENUE SHARE ANALYSIS 186
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS 187
10.5 MARKET SHARE ANALYSIS 187
FIGURE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET: MARKET SHARE ANALYSIS, 2021 188
10.6 COMPETITIVE BENCHMARKING 189
TABLE 181 COMPANY FOOTPRINT ANALYSIS 189
TABLE 182 PRODUCT & SERVICE FOOTPRINT ANALYSIS (25 COMPANIES) 190
TABLE 183 END-USER FOOTPRINT ANALYSIS (25 COMPANIES) 191
TABLE 184 REGIONAL FOOTPRINT ANALYSIS (25 COMPANIES) 192
10.7 COMPANY EVALUATION QUADRANT, 2021 193
10.7.1 STARS 193
10.7.2 PERVASIVE PLAYERS 193
10.7.3 EMERGING LEADERS 193
10.7.4 PARTICIPANTS 193
FIGURE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT, 2021 194
10.8 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 195
10.8.1 PROGRESSIVE COMPANIES 195
10.8.2 DYNAMIC COMPANIES 195
10.8.3 RESPONSIVE COMPANIES 195
10.8.4 STARTING BLOCKS 195
FIGURE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 196
10.9 COMPETITIVE SCENARIO 197
10.9.1 PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS 197
TABLE 185 INFECTION SURVEILLANCE SOLUTIONS MARKET: PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS, 2020–2022 197
10.9.2 DEALS 197
TABLE 186 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEALS, 2020–2022 197
10.9.3 OTHER DEVELOPMENTS 199
TABLE 187 INFECTION SURVEILLANCE SOLUTIONS MARKET: OTHER DEVELOPMENTS, 2020–2022 199

11 COMPANY PROFILES 200
(Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS 200
11.1.1 BECTON, DICKINSON AND COMPANY 200
TABLE 188 BD: COMPANY OVERVIEW 200
FIGURE 34 BD: COMPANY SNAPSHOT, 2022 201
TABLE 189 BD: PRODUCTS & SERVICES OFFERED 202
TABLE 190 BD: PRODUCT LAUNCHES/ENHANCEMENTS 202
TABLE 191 BD: DEALS 203
11.1.2 CERNER CORPORATION 204
TABLE 192 CERNER CORPORATION: COMPANY OVERVIEW 204
FIGURE 35 CERNER CORPORATION: COMPANY SNAPSHOT, 2021 205
TABLE 193 CERNER CORPORATION: PRODUCTS & SERVICES OFFERED 206
TABLE 194 CERNER CORPORATION: DEALS 206
11.1.3 PREMIER, INC. 208
TABLE 195 PREMIER, INC.: COMPANY OVERVIEW 208
FIGURE 36 PREMIER, INC.: COMPANY SNAPSHOT, 2022 209
TABLE 196 PREMIER, INC.: PRODUCTS & SERVICES OFFERED 209
TABLE 197 PREMIER, INC.: PRODUCT LAUNCHES/ENHANCEMENTS 210
TABLE 198 PREMIER, INC.: DEALS 211
11.1.4 BAXTER INTERNATIONAL INC. 213
TABLE 199 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW 213
FIGURE 37 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT, 2021 214
TABLE 200 BAXTER INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED 214
11.1.5 WOLTERS KLUWER N.V. 216
TABLE 201 WOLTERS KLUWER N.V.: COMPANY OVERVIEW 216
FIGURE 38 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT, 2021 217
TABLE 202 WOLTERS KLUWER N.V.: PRODUCTS & SERVICES OFFERED 217
TABLE 203 WOLTERS KLUWER N.V.: LAUNCHES/ENHANCEMENTS 218
TABLE 204 WOLTERS KLUWER N.V.: OTHERS 218
11.1.6 MERATIVE 220
TABLE 205 MERATIVE: COMPANY OVERVIEW 220
TABLE 206 MERATIVE: PRODUCTS & SERVICES OFFERED 220
TABLE 207 MERATIVE: OTHERS 221
11.1.7 ECOLAB 222
TABLE 208 ECOLAB: COMPANY OVERVIEW 222
FIGURE 39 ECOLAB: COMPANY SNAPSHOT, 2021 223
TABLE 209 ECOLAB: PRODUCTS & SERVICES OFFERED 223
TABLE 210 ECOLAB: PRODUCT LAUNCHES/ENHANCEMENTS 224
TABLE 211 ECOLAB: DEALS 224
TABLE 212 ECOLAB: OTHERS 224
11.1.8 BIOMÉRIEUX SA 225
TABLE 213 BIOMÉRIEUX SA: COMPANY OVERVIEW 225
FIGURE 40 BIOMÉRIEUX SA: COMPANY SNAPSHOT, 2021 226
TABLE 214 BIOMÉRIEUX SA: PRODUCTS & SERIVCES OFFERED 226
TABLE 215 BIOMÉRIEUX SA: PRODUCT LAUNCHES/ENHANCEMENTS 227
TABLE 216 BIOMÉRIEUX SA: DEALS 228
11.1.9 GOJO INDUSTRIES, INC. 229
TABLE 217 GOJO INDUSTRIES, INC.: COMPANY OVERVIEW 229
TABLE 218 GOJO INDUSTRIES, INC.: PRODUCTS & SERVICES OFFERED 229
TABLE 219 GOJO INDUSTRIES: PRODUCT LAUNCHES/ENHANCEMENTS 230
11.1.10 RLDATIX 231
TABLE 220 RLDATIX: COMPANY OVERVIEW 231
TABLE 221 RLDATIX: PRODUCTS & SERVICES OFFERED 231
TABLE 222 RLDATIX: PRODUCT LAUNCHES/ENHANCEMENTS 232
TABLE 223 RLDATIX: DEALS 233
11.1.11 VIGILANZ CORPORATION 235
TABLE 224 VIGILANZ CORPORATION: COMPANY OVERVIEW 235
TABLE 225 VIGILANZ CORPORATION: PRODUCTS & SERVICES OFFERED 235
TABLE 226 VIGILANZ CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS 236
11.1.12 DEB GROUP LTD 237
TABLE 227 DEB GROUP LTD.: COMPANY OVERVIEW 237
TABLE 228 DEB GROUP LTD.: PRODUCTS & SERVICES OFFERED 237
11.1.13 CLINISYS 238
TABLE 229 CLINISYS: COMPANY OVERVIEW 238
TABLE 230 CLINISYS: PRODUCTS & SERVICES OFFERED 238
TABLE 231 CLINISYS: DEALS 239
11.1.14 BIOVIGIL HEALTHCARE SYSTEMS 240
TABLE 232 BIOVIGIL HEALTHCARE SYSTEMS: COMPANY OVERVIEW 240
TABLE 233 BIOVIGIL HEALTHCARE SYSTEMS: PRODUCTS & SERVICES OFFERED 240
TABLE 234 BIOVIGIL HEALTHCARE SYSTEMS: DEALS 241
11.1.15 VECNA TECHNOLOGIES 242
TABLE 235 VECNA TECHNOLOGIES: COMPANY OVERVIEW 242
TABLE 236 VECNA TECHNOLOGIES: PRODUCTS & SERVICES OFFERED 242
11.1.16 HARRIS HEALTHCARE 244
TABLE 237 HARRIS HEALTHCARE: COMPANY OVERVIEW 244
TABLE 238 HARRIS HEALTHCARE: PRODUCTS & SERVICES OFFERED 244
TABLE 239 HARRIS HEALTHCARE: DEALS 245
11.1.17 PERAHEALTH 246
TABLE 240 PERAHEALTH: COMPANY OVERVIEW 246
TABLE 241 PERAHEALTH: PRODUCTS & SERVICES OFFERED 246
TABLE 242 PERAHEALTH: PRODUCT LAUNCHES/ENHANCEMENTS 247
TABLE 243 PERAHEALTH: DEALS 247
TABLE 244 PERAHEALTH: OTHERS 248
11.1.18 MEDEXTER HEALTHCARE 249
TABLE 245 MEDEXTER HEALTHCARE: COMPANY OVERVIEW 249
TABLE 246 MEDEXTER HEALTHCARE: PRODUCTS & SERVICES OFFERED 249
TABLE 247 MEDEXTER HEALTHCARE: PRODUCT LAUNCHES/ENHANCEMENTS 250
11.1.19 CENTRAK 251
TABLE 248 CENTRAK: COMPANY OVERVIEW 251
TABLE 249 CENTRAK: PRODUCTS & SERVICES OFFERED 251
TABLE 250 CENTRAK: PRODUCT LAUNCHES 252
TABLE 251 CENTRAK: DEALS 252
TABLE 252 CENTRAK: OTHERS 253
11.1.20 CKM HEALTHCARE INCORPORATED 254
TABLE 253 CKM HEALTHCARE INCORPORATED: COMPANY OVERVIEW 254
TABLE 254 CKM HEALTHCARE INCORPORATED: PRODUCTS & SERVICES OFFERED 254
11.2 OTHER PLAYERS 255
11.2.1 ASOLVA INC. 255
11.2.2 POINTCLICKCARE 255
11.2.3 VITALACY INC. 256
11.2.4 STANLEY HEALTHCARE 257
11.2.5 VIZZIA TECHNOLOGIES 258
*Details on Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 259
12.1 DISCUSSION GUIDE 259
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 263
12.3 CUSTOMIZATION OPTIONS 265
12.4 RELATED REPORTS 265
12.5 AUTHOR DETAILS 266

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • サプライチェーン分析の世界市場予測（～2027）：コンポーネント別、ソフトウェア別、サービス別、展開形態別、組織規模別、産業別、地域別
  • 服薬管理の世界市場2024年～2032年：ソフトウェア別、サービス別、デリバリー方式別、エンドユーザー別、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(HIT4380-23 )"世界の感染監視ソリューション市場（～2027）：ソフトウェア別、サービス別、エンドユーザー別、地域別" (英文：Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities), and Region- Global Forecast to 2027)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。